Pfizer, Moderna says studies underway on children under 12; Anand says enough supply once approved

Pfizer and Moderna officials said Tuesday that studies were underway on COVID-19 vaccines for those children under 12 though advised it would still take some time before they could submit data to Health Canada for approval. However, Public Services and Procurement Minister Anita Anand said that with about 68 million vaccine doses expected in country by the end of the week, they’ll have enough doses for additional age groups once approved.

• COVID-19 vaccine trial data for kids coming by end of year: Pfizer
• Ontario pharmacists groups says province in `critical’ period to use up Moderna shots